E-mail

E-mail a Wiley Online Library Link

Mark Schiffman Integration of human papillomavirus vaccination, cytology, and human papillomavirus testing Cancer Cytopathology 111

Version of Record online: 8 MAY 2007 | DOI: 10.1002/cncr.22751

By removing the most evident and threatening cytologic, colposcopic, and human papillomavirus (HPV) testing results from cervical cancer prevention programs, successful HPV type 16 (HPV-16) and HPV-18 prophylactic vaccination will leave behind more equivocal and less predictive abnormalities. This is good news for women; however, if we vaccinate widely, we will need to adjust the rest of the cervical cancer prevention program.

Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf

Required = Required Field

SEARCH